Search
for
Sort by
Research 211–240 of 1000+
- Polycystic ovary syndrome in men
- Sexual dysfunction, including hypoactive sexual desire disorder: Diagnosis and treatment recommendations
- SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Molecular epidemiology of hypospadias: Review of genetic and environmental risk factors
- Anti-Acne Agents Attenuate FGFR2 Signal Transduction in Acne
- MON-336 Ovaries Reveal Their Inner Testes
- Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
- Hair Loss in Women
- Ethinylestradiol/Chlormadinone Acetate
- Hormonal contraceptives: pharmacology tailored to women's health
- Transcriptome Analysis Reveals an Inhibitory Effect of Dihydrotestosterone-Treated 2D- and 3D-Cultured Dermal Papilla Cells on Hair Follicle Growth
- Prevalence of hormonal and endocrine dysfunction in patients with lichen planopilaris (LPP): A retrospective data analysis of 168 patients
- Eruptive Vellus Hair Cysts: Report of a New Case with Immunohistochemical Study and Literature Review
- Acquired scalp alopecia. Part II: A review
- Cutaneous Manifestations of PCOS
- 8 Pathogenesis and Classification of Female Pattern Hair Loss
- Polycystic Ovary Syndrome
- Testosterone Hormone ; Clinical Indications, Dysregulation and Therapeutic methods
- Hirsutism and Menstrual Irregularity in a 16-year-old Girl
- Prepubertal pattern hair loss
- Female Pattern Hair Loss
- 2-Substituted 4-(Thio)chromenone 6-<i>O</i>-Sulfamates: Potent Inhibitors of Human Steroid Sulfatase
- Severe Hyperandrogenemia and Insulin Resistance in a 12-Year-Old Girl
- Diagnosis of Polycystic Ovary Syndrome
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia
- Dermatological problems of the puberty
- IMPACTS OF HYPERANDROGENISM IN MENACMEN WITH POLYCYSTIC OVARY SYNDROME: A LITERATURE REVIEW
- 013 Prostaglandin D2 enhances testosterone metabolism by ROS-mediated altered redox potential in keratinocytes